Advertise
Urology Times® offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Let's work together - Contact Us!
Advertisement
Advertisement
Trending on Urology Times
1
Rethinking Testosterone Therapy After the FDA Label Revisions
2
FDA clears phase 1/2 trial of androgen receptor antagonist in mCRPC
3
BPH treatment patterns: Understanding regional differences in baseline ED treatment
4
Gedatolisib plus darolutamide: Early findings in mCRPC
5
